BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32030554)

  • 21. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.
    Bishop LA; Richter KS; Patounakis G; Andriani L; Moon K; Devine K
    Fertil Steril; 2017 Dec; 108(6):980-987. PubMed ID: 29202975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
    Scheffer JAB; Scheffer B; Scheffer R; Florencio F; Grynberg M; Lozano DM
    JBRA Assist Reprod; 2018 Sep; 22(3):215-220. PubMed ID: 29949322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ovarian response parameters and the synergistic effect of assisted reproduction of poor ovarian response treated with platelet rich plasma: systematic review and meta-analysis.
    Li W; Xu J; Deng D
    BMC Womens Health; 2024 Apr; 24(1):263. PubMed ID: 38678276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study.
    Barad DH; Albertini DF; Molinari E; Gleicher N
    Hum Reprod Open; 2022; 2022(3):hoac027. PubMed ID: 35795849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.
    Devine K; Mumford SL; Wu M; DeCherney AH; Hill MJ; Propst A
    Fertil Steril; 2015 Sep; 104(3):612-19.e3. PubMed ID: 26049057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis.
    Wu L; Su F; Luo P; Dong Q; Ma M; Ye G
    Platelets; 2024 Dec; 35(1):2292612. PubMed ID: 38214306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latent genital tuberculosis adversely affects the ovarian reserve in infertile women.
    Jirge PR; Chougule SM; Keni A; Kumar S; Modi D
    Hum Reprod; 2018 Jul; 33(7):1262-1269. PubMed ID: 29897442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
    Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
    Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels ≥20 mIU/mL.
    Kushnir VA; Safdie M; Darmon SK; Albertini DF; Barad DH; Gleicher N
    Reprod Sci; 2018 Jun; 25(6):893-898. PubMed ID: 28264624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced reproductive age and fertility.
    Liu K; Case A;
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1165-1175. PubMed ID: 22082792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of hypogonadotropic hypogonadism on ovarian reserve and response.
    Cecchino GN; Canillas GM; Cruz M; García-Velasco JA
    J Assist Reprod Genet; 2019 Nov; 36(11):2379-2384. PubMed ID: 31625035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of blood groups with ovarian reserve and outcome of in vitro fertilization treatment.
    Awartani K; Al Ghabshi R; Al Shankiti H; Al Dossari M; Coskun S
    Ann Saudi Med; 2016; 36(2):116-20. PubMed ID: 27031784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.